Novartis
We helped Novartis highlight the importance of investing in neglected diseases. Crafting a compelling narrative, we secured a sponsored report in the FT, reaching 22.4 million through print and digital platforms, amplifying awareness among an influential stakeholder audience.
Business Objectives
Disciplines
Sector
